Caribou Appoints Manfred Schauer to Advisory Board

equities Canada |

March 17th, 2015, VANCOUVER, B.C. – CARIBOU KING RESOURCES LTD. (“Caribou” or the “Company”) (CKR:CA) (CB8-FRANKFURT) is pleased to announce the appointment of Mr. Manfred Schauer to the Company’s Advisory Board.

Mr. Schauer is a seasoned international banker, entrepreneur and investor with over 44 years of business experience, 37 years of which he worked and lived in the Asia Pacific region. He was educated in Germany, followed by a 15 year career with Deutsche Bank. Based in Hong Kong as Regional Treasurer he was responsible for asset and liability and risk management, in addition to all money market and foreign exchange trading operations for Deutsche Bank’s Asia Pacific subsidiary network in 13 countries. Mr. Schauer was then responsible for developing similar regional treasury capabilities for two other international banks based in Hong Kong and Japan for another 5 years. From New Zealand Mr. Schauer now runs his own independent consulting business which has involved a wide range of international projects from corporate finance to property development to technology and to the resources sector.



“We are very pleased to appoint Mr. Manfred Schauer to Caribou King’s advisory board. His international experience will help guide ongoing and future business opportunities with European parties regarding Caribou King’s rapidly advancing graphite assets.” stated Michael B. England, CEO & Director of Caribou King.

Caribou King Resources Ltd. flagship Buckingham flake/lump graphite property has been host to two ultra high purity graphite discoveries in 2015. Tests undertaken at SGS Lakefield’s lab have shown exceptional results from its first two beneficiation tests from two separate samples taken from locations 250 meters apart. Further mesh size analysis will be released when available.

For more information, please visit the website at www.caribouking.com.

ON BEHALF OF THE BOARD

Michael England, CEO
Caribou King Resources Ltd.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…